Mitoxantrone (novantrone): a review of experimental and early clinical studies
- 30 June 1983
- journal article
- clinical trial
- Published by Elsevier in Cancer Treatment Reviews
- Vol. 10 (2) , 103-115
- https://doi.org/10.1016/0305-7372(83)90008-7
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- Pharmacology of mitoxantrone in cancer patientsCancer Chemotherapy and Pharmacology, 1982
- Plasma levels of 1,4-dihydroxy-5,8-bis ({2-[(2--hydroxylethyl)amino]ethyl}amino)-9,10-anthracenedione dihydrochloride (DHAD) in humansInternational Journal of Pharmaceutics, 1981
- Interactions of a new antitumor agent, 1,4-dihydroxy-5,8-bis[[2-[(2-hydroxyethyl)amino]-ethyl]amino]-9,10-anthracenedione, with nucleic acidsBiochemical Pharmacology, 1981
- Phase I clinical trial of mitoxantrone: A new anthracenedione anticancer drugCancer Chemotherapy and Pharmacology, 1980
- Comparison of Antineoplastic Activity of Aminoethylaminoanthraquinones and Anthracycline AntibioticsJournal of Pharmaceutical Sciences, 1979
- Primary Bioassay of Human Tumor Stem CellsScience, 1977
- Integration of chemotherapy into combined modality treatment of solid tumors: VII. Adenocarcinoma of the breastCancer Treatment Reviews, 1976
- Evaluation of the binding of some substituted anthraquinones and naphthacenequinones to DNAJournal of Pharmacy and Pharmacology, 1976
- The interaction of aminoalkylaminoanthraquinones with deoxyribonucleic acidJournal of Pharmacy and Pharmacology, 1975